Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 17/20 | 0.54 |
| ▸ | PPARG | P37231 | 15/20 | 0.54 |
| ▸ | PNMT | P11086 | 1/20 | 0.51 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.49 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23933859 | 1.00 | PPARA (0.54) | PPARAPPARGPNMTSRRPPARD | |
| SCHEMBL6071337 | 0.86 | PNMT (0.54) | PPARAPPARGPNMT | |
| SCHEMBL15446258 | 0.84 | SRR (0.68) | PPARAPPARGPNMTSRR | |
| SCHEMBL22264858 | 0.83 | PPARG (0.56) | PPARAPPARGSRRPPARD | |
| SCHEMBL5383259 | 0.83 | SRR (0.50) | PPARAPPARGSRRPPARD | |
| SCHEMBL22264856 | 0.83 | PPARG (0.56) | PPARAPPARGSRRPPARD | |
| SCHEMBL31321016 | 0.83 | PPARG (0.56) | PPARAPPARGSRRPPARD | |
| SCHEMBL9628212 | 0.81 | SRR (0.70) | PPARAPPARGSRRPPARD | |
| SCHEMBL2517934 | 0.81 | SRR (0.70) | PPARAPPARGSRRPPARD | |
| SCHEMBL16877217 | 0.81 | SRR (0.70) | PPARAPPARGSRRPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021217041-A1 | N-SUBSTITUTED ALPHA-AMINO AND ALPHA-HYDROXY CARBOXAMIDE DERIVATIVES | IMMVENTION THERAPEUTIX (US) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021217041-A1 | N-SUBSTITUTED ALPHA-AMINO AND ALPHA-HYDROXY CARBOXAMIDE DERIVATIVES | IMMVENTION THERAPEUTIX (US) | 2021-10-28 | — | — | WO | disclosed |